CDCA7

gene product
FLJ14736, JPO1
This gene was identified as a c-Myc responsive gene, and behaves as a direct c-Myc target gene. Overexpression of this gene is found to enhance the transformation of lymphoblastoid cells, and it complements a transformation-defective Myc Box II mutant, suggesting its involvement in c-Myc-mediated cell transformation. Two alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Antibodypedia Validation Initiative

Validation method

Application

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
77 antibodies from 20 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeAVIWBELICCIPIHCFC
Biorbyt
7 antibodies
Proteintech Group
1 antibody
Abnova Corporation
3 antibodies
Atlas Antibodies
1 antibody
Novus Biologicals
1 antibody
NovoPro Bioscience Inc.
1 antibody
Invitrogen Antibodies
3 antibodies
Affinity Biosciences
1 antibody
GeneTex
1 antibody
antibodies-online
26 antibodies
LifeSpan BioSciences, Inc.
8 antibodies
Aviva Systems Biology
2 antibodies
OriGene
2 antibodies
Creative Diagnostics
2 antibodies
MyBioSource
2 antibodies
Boster Biological Technology
1 antibody
Abbkine Scientific Co.Ltd.
1 antibody
Sigma-Aldrich
1 antibody
St John's Laboratory
1 antibody